The data is there. So why aren’t we using it?
Reflections from HLTH Europe 2026, where I [...]
Mind the gap: Inside the UK’s ADHD crisis
ADHD referrals in England have grown rapidly since 2020, [...]
Integrated care – are we there yet?
Ten years on from the journey to integration Ten [...]
From access to uptake: Reflections from EMIG’s quarterly meeting
CF presented at the Ethical Medicines Industry Group quarterly [...]
Dementia Action Week: what acting on dementia actually requires
One in three people with dementia in the UK [...]
The 2026 Health Bill – what does it mean for NHS?
The 2026 Health Bill is one of [...]
CF announced as finalists for the 2026 MCA Awards
The MCA has announced finalists for its 2026 awards, and [...]
The global awakening: How ADHD became the defining health system challenge of a generation
An explosion in ADHD interest Over the last 20 [...]
Reflections from IPPR’s new report launch – Bismarck versus Beveridge Revisited
Capital concerns I was in the room [...]
Agreement on pharmaceutical pricing between the United States and the United Kingdom
The UK and US governments have finalised [...]
